SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH M impact

Immunovant Files SEC Form

Immunovant, Inc. files with SEC, disclosure pending. Immunovant is a biopharmaceutical company.

IMVT

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.

Related stories